1. The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial*. Issue 11 (29th August 2022) Authors: Youssef, Jihad Georges; Lavin, Philip; Schoenfeld, David A.; Lee, Richard A.; Lenhardt, Rainer; Park, David J.; Fernandez, Javier Perez; Morganroth, Melvin L.; Javitt, Jonathan C.; Jayaweera, Dushyantha Journal: Critical care medicine Issue: Volume 50:Issue 11(2022) Page Start: 1545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗